PMID- 23376721 OWN - NLM STAT- MEDLINE DCOM- 20130903 LR - 20211203 IS - 1090-2104 (Electronic) IS - 0006-291X (Linking) VI - 432 IP - 2 DP - 2013 Mar 8 TI - Simvastatin inhibits ox-LDL-induced inflammatory adipokines secretion via amelioration of ER stress in 3T3-L1 adipocyte. PG - 365-9 LID - S0006-291X(13)00184-8 [pii] LID - 10.1016/j.bbrc.2013.01.094 [doi] AB - Adipocytes behave as a rich source of pro-inflammatory cytokines including tumor necrosis factor-alpha (TNF-alpha) and monocyte chemoattractant protein 1 (MCP-1). Endoplasmic reticulum (ER) stress in adipocytes can alter adipokines secretion and induce inflammation. The aim of this study is to evaluate the effect of simvastatin on the ox-LDL-induced ER stress and expression and secretion of TNF-alpha and MCP-1 in 3T3-L1 adipocytes. Differentiated adipocytes were treated with various concentrations of ox-LDL (0-100 mug/ml) for 24h with or without simvastatin pre-treatment. The protein expressions of ER stress markers, glucose-regulated protein 78 (GRP78) and C/EBP homology protein (CHOP), were determined by Western blot analysis. The mRNA expressions of TNF-alpha and MCP-1 were measured by real-time PCR. The protein release of TNF-alpha and MCP-1 in culture medium were evaluated by ELISA. Ox-LDL treatment led to significant up-regulation of GRP78 and CHOP in dose-dependent manner. The expressions of TNF-alpha and MCP-1 were dose-dependently increased at mRNA and protein levels after ox-LDL intervention. The effects of ox-LDL on adipocytes were abolished by pre-treatment with 4-phenylbutyrate (4-PBA), a chemical chaperone known to ameliorate ER stress. Simvastatin could inhibit ox-LDL-induced ER stress and reduce the expression of TNF-alpha and MCP-1 at mRNA and protien level in dose dependent manner. In conclusion, ox-LDL can stimulate the expression and secretion of TNF-alpha and MCP-1 through its activation of ER stress in adipocytes. Simvastatin might exert direct anti-inflammatory effects in adipocytes through amelioration of ER stress. CI - Copyright (c) 2013 Elsevier Inc. All rights reserved. FAU - Wu, Zhi-hong AU - Wu ZH AD - Department of Cardiology, The Second Xiangya Hospital of Central South University, Middle Ren-Min Road No. 139, Changsha, Hunan 410011, PR China. FAU - Chen, Ya-qin AU - Chen YQ FAU - Zhao, Shui-ping AU - Zhao SP LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20130131 PL - United States TA - Biochem Biophys Res Commun JT - Biochemical and biophysical research communications JID - 0372516 RN - 0 (Adipokines) RN - 0 (Chemokine CCL2) RN - 0 (Endoplasmic Reticulum Chaperone BiP) RN - 0 (Hspa5 protein, mouse) RN - 0 (Hypolipidemic Agents) RN - 0 (Lipoproteins, LDL) RN - 0 (Tumor Necrosis Factor-alpha) RN - 0 (oxidized low density lipoprotein) RN - AGG2FN16EV (Simvastatin) SB - IM MH - 3T3-L1 Cells MH - Adipokines/*antagonists & inhibitors/metabolism MH - Animals MH - Chemokine CCL2/metabolism MH - Endoplasmic Reticulum Chaperone BiP MH - Endoplasmic Reticulum Stress/*drug effects MH - Hypolipidemic Agents/*pharmacology MH - Lipoproteins, LDL/*metabolism/pharmacology MH - Mice MH - Simvastatin/*pharmacology MH - Tumor Necrosis Factor-alpha/metabolism EDAT- 2013/02/05 06:00 MHDA- 2013/09/04 06:00 CRDT- 2013/02/05 06:00 PHST- 2013/01/11 00:00 [received] PHST- 2013/01/24 00:00 [accepted] PHST- 2013/02/05 06:00 [entrez] PHST- 2013/02/05 06:00 [pubmed] PHST- 2013/09/04 06:00 [medline] AID - S0006-291X(13)00184-8 [pii] AID - 10.1016/j.bbrc.2013.01.094 [doi] PST - ppublish SO - Biochem Biophys Res Commun. 2013 Mar 8;432(2):365-9. doi: 10.1016/j.bbrc.2013.01.094. Epub 2013 Jan 31.